ארא-סל 5 גרם - Ara-cell 5 g
ש××× ×× !
ש×××ק ×תר××¤× ××פסק, ×××× ×תר××¤× ×× × ×צ×ת ×-×××ר ×תר×פ×ת ×©× ××©×¨× ××ר×××ת.
×× ××××¢ ×¦×¤× ×××××ש ש×××ק, ר×× ××××¢× ×ת×××× ×-×ער×ת ×××××¢×ת ×¢× ×פסקת ש×××ק תר×פ×ת.
ת×ר×× ×××××¢× ××× 29.1.2023.
ש×××ק ×תר××¤× ××פסק, ×××× ×תר××¤× ×× × ×צ×ת ×-×××ר ×תר×פ×ת ×©× ××©×¨× ××ר×××ת.
×× ××××¢ ×¦×¤× ×××××ש ש×××ק, ר×× ××××¢× ×ת×××× ×-×ער×ת ×××××¢×ת ×¢× ×פסקת ש×××ק תר×פ×ת.
ת×ר×× ×××××¢× ××× 29.1.2023.
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ××× ×× ×× × ×ספ×× | ||||||
|---|---|---|---|---|---|---|
| ק×××¦× ×¤×¨×ק×××××ת (ATC4) | L01BC Pyrimidine analogues | |||||
| ×ר××× ×¤×¢×× (ATC5) | Â
| |||||
| צ×רת ××ª× | ת××-×ר××× - I.V | |||||
| צ×רת ××× ×× | תר××× ×××× ×ª ת×××¡× ×××× ×¤××××, CONCENTRATE FOR SOLUTION FOR INFUSION ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× | |||||
| ×ת×××× | ARA-cell® 100 mg/ml is used in combination with other cytostatic agents in high-dose therapy for:⢠refractory non-Hodgkinâs lymphoma⢠refractory acute non-lymphocytic leukaemia⢠refractory acute lymphoblastic leukaemia⢠recurrent cases of acute leukaemia⢠types of leukaemia with special risk: â secondary leukaemia following previous chemotherapy and/or radiation treatment â manifest leukaemia following transformation of pre-leukaemia⢠consolidation of the remission of acute non-lymphocytic leukaemia in patients under 60 years of age.
| |||||
× ×ª×× × ×¡× [ ×צ×× ]
| ||||||
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
  | |||||
| ×¢××× ×צר×× |  |
|---|
| ער××× ××××ק×רפ××× | ער××× ×§×©×ר×× ××××ק×רפ××× |
|---|---|
| ×ר×-×¡× 5 ××¨× ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | ×××ר×× ×-PubMed |
|---|---|
| ××××¢ ×רשת | RxList WebMD Drugs.com |
| ×©× ××¦×¨× | STADAPHARM GMBH, GERMANY |
| ×©× ××¢× ×ר×ש×× | MBI PHARMA LTD., ISRAEL |
| ר×ש××× | ת×ר×× ××ש×: 06/2014. ר×ש××× ×ת×ר××: 03/2016 |
| ת×ר×× ×¢×××× ××ר×× | 29.1.2023 |